Sterling Consolidated Corp. STCC
Last Post: 11/29/2018 11:18:53 AM
Board Marks: 4
Posts Today: 0
Board Views Today: 24
02/10/2017 11:05:54 AM
02/10/2017 11:05:22 AM
02/10/2017 11:04:53 AM
02/09/2017 4:39:40 PM
02/09/2017 4:39:22 PM
02/09/2017 4:38:57 PM
02/09/2017 4:37:11 PM
02/09/2017 3:35:18 PM
02/09/2017 3:34:42 PM
02/09/2017 3:34:22 PM
02/08/2017 1:17:00 PM
02/08/2017 11:46:18 AM
02/08/2017 11:44:49 AM
02/08/2017 11:44:31 AM
02/02/2017 11:51:26 AM
11/15/2016 1:11:23 PM
11/15/2016 1:10:42 PM
11/15/2016 1:10:15 PM
11/15/2016 11:45:30 AM
11/15/2016 11:44:44 AM
11/15/2016 11:43:26 AM
11/15/2016 10:19:50 AM
11/15/2016 10:18:12 AM
11/14/2016 1:57:16 PM
11/14/2016 12:42:23 PM
11/14/2016 12:40:21 PM
11/14/2016 12:39:50 PM
11/14/2016 11:24:34 AM
11/14/2016 11:23:44 AM
11/14/2016 11:21:26 AM
11/14/2016 10:31:59 AM
11/14/2016 10:31:06 AM
11/14/2016 10:30:12 AM
11/11/2016 1:41:50 PM
11/11/2016 1:41:11 PM
11/11/2016 1:40:31 PM
11/11/2016 1:39:59 PM
11/11/2016 12:32:35 PM
11/11/2016 12:31:37 PM
11/11/2016 12:31:02 PM
11/11/2016 11:13:34 AM
11/11/2016 11:11:38 AM
11/11/2016 11:11:05 AM
11/10/2016 12:52:38 PM
11/10/2016 12:51:50 PM
11/10/2016 12:50:57 PM
11/10/2016 12:50:10 PM
11/10/2016 11:35:47 AM
11/10/2016 11:34:51 AM
11/10/2016 11:34:14 AM
Recent Articles
- Samsung Chairman's Family Sells Shares to Meet Inheritance Tax
- Clinical Breakthrough: ITM's Promising Trial Results Unveiled
- Celcuity's Promising Phase 1 Trial Results on Prostate Cancer Therapy
- New Findings on Gedatolisib’s Efficacy for Advanced Breast Cancer
- Concerns Raised Over Elon Musk's Striking Compensation Package
- Qustodio: Elevating Digital Child Safety on iPhones in 2025
- Celcuity's Phase 3 VIKTORIA-1 Trial for PIK3CA Mutants Advances
- Innovative Gedatolisib and Darolutamide Study Shows Promise
- New Insights on Gedatolisib's Role in Breast Cancer Treatment
- Meta and Blue Owl Collaborate on $30 Billion AI Data Center
- Kura Oncology's Latest Insights on FTI Program Advancements
- Nvidia's Market Share Plummets: CEO Jensen Huang's Concerns
- Kura Oncology Unveils Promising Data from FTI Programs at ESMO
- Olema Oncology Shares Promising Findings on Palazestrant
- General Oncology's SHARON Trial Yields Encouraging Results
- Revitalizing ER+ Breast Cancer with Palazestrant and Ribociclib
- Corbus Pharmaceuticals Reports Promising Results for CRB-701
- Promising Data on NX-1607: A Breakthrough in Cancer Treatment
- Florida Cancer Specialists Revolutionizing Oncology Research
- Salesforce CEO's Apology Sparks Controversy in Tech Industry
- Significant Progress in Advanced Breast Cancer Treatments with Giredestrant
- Breakthrough in HPV Carcinoma Treatment by SCG Cell Therapy
- Innovative Immunotherapy SCG142 Shows Promise in Cancer Treatment
- Trump's Decision on Ukraine Missiles Revealed After Key Talks
- Kevin O'Leary Highlights Importance of American Dream for Leadership
- Transformational Program for Millennial Professionals Unveiled
- Investigation Launched as PeopleGuru Faces Data Breach Crisis
- Trump Seeks Supreme Court Approval for National Guard in Chicago
- Westhaven Gold Corp. Announces Executive Update and Future Plans
- Trump Commutes Santos' Prison Sentence Amid Public Support
- A New Toolkit to Enhance Executive Function Skills in Education
- Westhaven Gold Announces Leadership Changes and Operations Update
- Aeroméxico's Exciting Global Offering: What You Need to Know
- Investigation Into Luminar Technologies Signals Serious Concerns
- Inquiry into Hasbro Leadership: Legal Investigation Unfolds
- Legal Investigation of CVS/Aetna Medicare Advantage Claims
- Deadline Approaches for Dow Investors in Class Action Case
- Investors Alert: Key Class Action Lawsuit Against V.F. Corporation
- Fluor Corporation Lawsuit Update: Important Investor Info
- Investors Urged to Act Before KBR Class Action Deadline
- Cytokinetics Class Action Lawsuit Update: Important Deadlines
- Important Legal Update for WPP Investors: Key Deadline Approaches
- Molina Healthcare Faces Class Action Lawsuit Amid Financial Turmoil
- Marex Group Faces Class Action Lawsuit Over Financial Misconduct
- Lead the Charge: Join the Fly-E Group Securities Lawsuit
- Investigation into MoonLake Immunotherapeutics Raises Concerns
- MoonLake Immunotherapeutics: Investors Investigate Potential Fraud
- Investigation of MoonLake Immunotherapeutics Raises Concerns
- Leadership Changes at Silver Mountain Resources: What to Expect
- Canton Fair Launches Enhanced Services to Boost Global Trade
